OpenURL Connection Search

Select item for more details and to access through your institution.

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.
Published in:
FASEB Journal, 2011, v. 25, n. 12, p. 4127, doi. 10.1096/fj.10-179192
By:
- Foulds, Penelope G.;
- Mitchell, J. Douglas;
- Parker, Angela;
- Turner, Roisin;
- Green, Gerwyn;
- Diggle, Peter;
- Hasegawa, Masato;
- Taylor, Mark;
- Mann, David;
- Allsop, David
Publication type:
Article
Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.
Published in:
Acta Neuropathologica, 2009, v. 118, n. 5, p. 647, doi. 10.1007/s00401-009-0594-0
By:
- Foulds, Penelope G.;
- Davidson, Yvonne;
- Mishra, Manjari;
- Hobson, David J.;
- Humphreys, Kirsty M.;
- Taylor, Mark;
- Johnson, Nancy;
- Weintraub, Sandra;
- Akiyama, Haruhiko;
- Arai, Tetsuaki;
- Hasegawa, Masato;
- Bigio, Eileen H.;
- Benson, Fiona E.;
- Allsop, David;
- Mann, David M. A.
Publication type:
Article
Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Published in:
Acta Neuropathologica, 2009, v. 117, n. 1, p. 55, doi. 10.1007/s00401-008-0456-1
By:
- Kasai, Takashi;
- Tokuda, Takahiko;
- Ishigami, Noriko;
- Sasayama, Hiroshi;
- Foulds, Penelope;
- Mitchell, Douglas J.;
- Mann, David M. A.;
- Allsop, David;
- Masanori Nakagawa
Publication type:
Article
TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration.
Published in:
Acta Neuropathologica, 2008, v. 116, n. 2, p. 141, doi. 10.1007/s00401-008-0389-8
By:
- Foulds, Penelope;
- McAuley, Erica;
- Gibbons, Linda;
- Davidson, Yvonne;
- Pickering-Brown, Stuart M.;
- Neary, David;
- Snowden, Julie S.;
- Allsop, David;
- Mann, David M. A.
Publication type:
Article
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype.
Published in:
Acta Neuropathologica, 2011, v. 122, n. 6, p. 703, doi. 10.1007/s00401-011-0879-y
By:
- Davidson, Yvonne;
- Raby, Samantha;
- Foulds, Penelope;
- Robinson, Andrew;
- Thompson, Jennifer;
- Sikkink, Stephen;
- Yusuf, Imran;
- Amin, Hanan;
- DuPlessis, Daniel;
- Troakes, Claire;
- Al-Sarraj, Safa;
- Sloan, Carolyn;
- Esiri, Margaret;
- Prasher, Vee;
- Allsop, David;
- Neary, David;
- Pickering-Brown, Stuart;
- Snowden, Julie;
- Mann, David
Publication type:
Article
A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.
Published in:
Scientific Reports, 2013, p. 1, doi. 10.1038/srep02540
By:
- Foulds, Penelope G.;
- Diggle, Peter;
- Douglas Mitchell, J.;
- Parker, Angela;
- Hasegawa, Masato;
- Masuda-Suzukake, Masami;
- Mann, David M. A.;
- Allsop, David
Publication type:
Article

Found: 6

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration.

TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype.

A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.